As Needed, Effective Nutritional Support for Migraine and Headache Sufferers*
MigreLief-NOW is a truly effective, non-prescription nutritional support for neurological and whole body comfort when you need it most.* A beneficial option for men, women, and children ages 2 and older, without the side-effects associated with the chronic use of NSAIDs, analgesics, and anti-inflammatories.
As with all Akeso products, MigreLief-NOW is a well-researched complex formula developed with an expert understanding of the profound link between human biology and the chemistry found in nature. The success of MigreLief-NOW is greatly attributed to the scientific research that Akeso Health Sciences performs to ensure the optimum combination of ingredients at clinically recognized doses, and to make certain that the extraction processes used do not cause degradation to occur during the life of the product.
Puracol® is a special profile of Feverfew (Tanacetum parthenium) unique to MigreLief. Delivered in a clinically studied optimum dose, Akeso Health Science’s proprietary Puracol® Feverfew provides a broad spectrum of naturally occurring and extracted beneficial phytochemicals to support proper cerebrovascular tone and function, as well as platelet aggregation that can otherwise lead to vasoconstriction.*
Magnesium contains two clinically known beneficial forms of magnesium in daily amounts critical for the inhibition of vasospasm and platelet aggregation in support of cerebral vascular tone.*
Cerevasc Ginger® is a proprietary blend of two forms of ginger; ginger contains more than 200 substances in its oils, which is why there is a wide-range of known benefits to human health. Benefits include helping to promote a healthy inflammatory response supported by many clinical studies.*
Aflapin® Boswellia Serrata is a proprietary licensed nutraceutical of Boswellia [with boswellic and beta boswellic acids], extracted using processes necessary to enhance absorption; historically used in traditional medicines and shown in clinical studies to support a response to occasional joint discomfot and to promote a healthy inflammatory response.*
can be used alone or in combination with any other MigreLief daily formula as needed
is non-drowsy, and thus perfect for busy days
is recommended by physicians and headache specialists
is non-prescription and drug free and does not interfere with prescription or OTC migraine drugs
does not cause rebound headaches
effective for all ages 2 years and older
does not contain butterbur, wheat, gluten, salt, soy, milk or dairy, nuts, corn, caffeine, or artificial flavorings or preservatives; non-GMO and vegan
is manufactured in an established GMP facility
maintains an effective track record with 3rd-party batch testing on every product by top, industry-focused lab under the guidance of a forensic expert, in business over 30 years
was researched and formulated by Akeso Health Sciences Chief Scientific Officer, Curt Hendrix, who holds advanced degrees in chemistry and clinical nutrition and has dedicated his life to providing innovative natural medicines
* These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
MigreLief-NOW — Fast-Acting for When You Need It Most
Serving Size: 2 Capsules • 30 Servings per Bottle
Per 2 Caps
Magnesium (as citrate and oxide)
Puracol® Feverfew** (whole leaf and extract)
Cerevasc Ginger*** (whole root and extract)
Aflapin® Boswellia Serrata**** (extract)
*No Daily Value established
**Puracol® is a proprietary combination of whole leaf feverfew that is high in naturally occurring phytochemicals and a special feverfew extract. Delivered in an optimum clinically studied dose; supports proper cerebrovascular tone and function, and platelet aggregation.*
***Cerevasc Ginger® is a proprietary combination of whole ginger rhizome and standardized ginger extract. A wide-range of known benefits including helping to promote a healthy inflammatory response; supported by many clinical studies.*
****Aflapin® [Boswellia Serrata] is a registered trademark of Laila Nutraceuticals. Form enhances absorption; boswellia has been historically used in traditional medicines and today shown in clinical studies to support a response to occasional pain and to promote a healthy inflammatory response.*
Choose MigreLief-NOW for fast-acting neurological and all-body comfort support when needed. Potent, safe, and effective for men, women and children ages 2 and older. We recommend keeping MigreLief-NOW on hand at all times!
Ages 14-Adult: Take 3-4 capsules with food. May repeat dose in 2 hours. Do not exceed 8 capsules in a 24-hour period. Do not exceed 4 capsules if combining with a MigreLief daily formula.
Ages 9-13: Take 1-2 capsules with food. May repeat dose in 2 hours. Do not exceed 4 capsules in a 24-hour period. Do not exceed 2 capsules if combining with a MigreLief daily formula
Ages 2-8: Take 1 capsule with food. May repeat dose in 2 hours. Do not exceed 2 capsules in a 24-hour period.
Caution: Not for use during pregnancy, during lactation, or by children under 2 years of age.
Potential side effects, though rare, can include:
Some individuals may experience transient diarrhea when ingesting magnesium.
Riboflavin (Vitamin B-2) can cause urine to become bright yellow. This is normal and harmless.
Some individuals can experience gastro-intestinal upset when taking dietary supplements.
Though rare, some people can feel achy, tired and experience a headache if they abruptly stop taking feverfew. Tapering off gradually is recommended after a longer period of continuous daily use. Reduce intake to one daily for a week, then one every other day for a week before stopping
Like most dietary supplements, it is recommended that MigreLief be discontinued one week before any surgery.
Brown D, Gaby A, Reichert R. Clinical Applications of Natural Medicine–Migraine. NPRC Condition-Specific Monograph Series, 1997.
Lawrence Review of Natural Products, September 1994.
Awang DVC. Herbal Medicine, Feverfew. Canadian Pharm J 1989; 122:266-70.
Heptinstall S, Awang DVC, Dawson BA, et al. Parthenolide Content and Bioactivity of Feverfew (Tanacetum parthenium). Estimation of Commercial and Authenticated Feverfew Products. J Pharm Pharmacol 1992; 44:391-5.
Pugh WJ, Sambo K. Prostaglandin Synthetase Inhibitors in Feverfew. J Pharm Pharmacol 1988; 40-743-5.
Heptinstall S, White A, Williamson L, Mitchell JRA. Extracts of Feverfew Inhibit Granule Secretion in Blood Platelets and Polymophonuclear Leukocytes. Lancet 1985; i:1071-4.
Makheja AN, Bailey JM. A Platelet Phospholipase Inhibitor from the Medicinal Herb Feverfew (Tanacetum parthenium). Prostagland Leukotrienes Med 1982;8:653-60.
Sumner H, Salan U, Knight DW, Hoult JRS. Inhibition of 5-Lipoxygenase and Cyclo-oxygenase in Leukocytes by Feverfew. Biochem Pharmacol 1992;43:2313-20.
Johnson ES, Kadam NP, Hylands DM, Hylands PF. Efficacy of Feverfew As prophylactic Treatment of Migraine. British Med J 1985; 291:569-73.
Murphy JJ. Heptinstall S, Mitchell JRA. Randomized Double-Blind Placebo-Controlled Trial of Feverfew in Migraine Prevention. Lancet 1988; ii:189-92.
Altura BM. Calcium Antagonist Properties of Magnesium: Implications for Anti-migraine Actions. Magnesium 1985; 4:169-75.
Ramadan NM, Halvorson H, Vande-Linde A, et al. Low Brain Magnesium in Migraine. Headache 1989; 29:590-93.
Weaver K. Magnesium and Migraine. Headache 1990; 30:168.
Faccinetti F, Sances G, Borella P, et al. Magnesium Prophylaxis of Menstrual Migraine: Effects on Intra-cellular Magnesium. Headache 1991; 31:298-304.
Peikert A, Wilimzig C, Kohne-Volland R. Prophylaxis of Migraine with Oral Magnesium: Results from a Prospective, Multi-Center, Placebo-Controlled and Double-Blind Randomized Study. Cephalalgia 1996; 16:257-63.
Pfaffenrath V, Wessely P, Meyer C, et al. Magnesium in the Prophylaxis of Migraine–A Double-Blind, Placebo-Controlled Study. Cephalalgia 1996;16:436-40.
Schoenen J, Lenaerts M, Bastings E. High-dose Riboflavin as a Prophylactic Treatment of Migraine: Results of an Open Pilot Study. Cephalalgia 1994l14:328-9
Schoenen J, Jacquy J, Lenaerts M. Effectiveness of high-dose riboflavin in migraine prophylaxis: a randomised controlled trial. Neurology 1998; 50: 46670.
Boehnke C, Reuter U, Flach U, Schuh-Hofer S, Einhaupl KM, Arnold G. High-dose riboflavin treatment is efficacious in migraine prophylaxis: an open study in a tertiary care centre. Eur J Neurol. 2004 Jul;11(7):475-7.
Maria Condò1, Annio Posar1, Annalisa Arbizzani1 and Antonia Parmeggiani1 Riboflavin prophylaxis in pediatric and adolescent migraine. The Journal of Headache and Pain: Volume 10, Number 5 / October, 2009
Schellenberg R. Treatment for PMS with agnus castus. BMJ. 2001 Han 20;322(7279):134-7
Haut-und Gesch. 1964; 36:220 Giss, G. Rothenburg,W.
Ggw 1967;106:124-6 Amann W. Improvement of acne vulgaris with Agnus castus
Zbl GynSkol 1959 81:701 Bleier, W.
Medica Emperica 1990, 9”494-502 Bohnert, K.J. Hahs, G. Phytotherapy in Gynecology and Obstetrics (Chasteberry) Acta
clin. Biochem Nutr. 1993;14:211-218 Therapeutic evaluation of the effect of biotin on hyperglycemia in patients with non-insulin dependent diabetes mellitus.
2007 Nov-Dec;47(10):1436-43 Insulin metabolism is altered in migraineurs. Cavestro, C. et al
J Obstet Gynaecol 1990;97:847-52 vitamin B6 in the treatment of the premenstrual syndrome- a review, Kleijnen J. Riet GT et al
Int J]. Gunn AD Vitam Nutr Res. 1985;Suppl 27:213–24 review
J Int Med Res 1985;13:174-9 Controlled trial of B6 in PMS Harris RI, Deand BC
Lancet 1985;1399 B6 and PMS Brush MG, Perry M.
BMJ 1999;318;1375-81 Systematic Review B6 and PMS Dimmock PW et al
Arch Dermatol 1974;110:130-131 B6 for premenstrual acne Snider B et al
J Invest Dermatol 1942;5:143-8 B6 on resistant adolescent acne. Joliffe N et al
Clin Neuropharmacol 30(1):25-38 Electrical mapping of the effect of theanine. Higgin BA et al
Bio Psychol 74(1):39-45 Theanine reduces psychological and physiological stress Ozeki M et al.
Biol Psychol 77(2):113-22 Effects of theanine and caffeine on cognition and mood Kimura k et al.